通过调节m6A的NLRP3修改,FTO调解了糖尿病病的进展
1Department of Nephrology, Guang'anmen Hospital South Campus, China Academy of Chinese Medical Sciences, No.138, Xingfeng Street, Huangcun Village, DaXing District, Beijing, 102600, China.
BMC nephrology
|October 10, 2024
概括
脂肪质量和与肥胖相关的蛋白质 (FTO) 通过调节NLRP3.3的N6-甲基氨酸 (m6A) 修饰来抑制糖尿病病 (DKD) 的进展. 在DKD模型中,FTO过度表达减轻了损伤,并抑制了 pyroptosis.
科学领域:
- 分子生物学分子生物学
- 生物化学 生化学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 糖尿病病 (DKD) 是糖尿病的一个主要并发症.
- 导致DKD进展的精确分子机制需要进一步阐明.
- 在DKD中,FTO (脂肪质量和与肥胖相关的蛋白质) 的作用仍未完全理解.
研究的目的:
- 研究FTO在糖尿病病 (DKD) 进展中的特定机制.
- 确定FTO在管状上皮细胞和体内DKD模型中的调节作用.
- 在DKD的背景下,探索FTO和NLRP3之间的相互作用.
主要方法:
- 使用HK-2细胞和小鼠建立了DKD模型.
- 量化了N6-甲基氨酸 (m6A) 度,FTO表达和NLRP3使用点滴,MeRIP,RT-qPCR和西部点滴.
- 通过CCK-8,流细胞测量,ELISA和组织学分析评估了细胞活力,热和损伤.
主要成果:
- 高葡萄糖诱导的HK-2细胞灭,升高的m6A水平,以及下调的FTO表达.
- 在高葡萄糖处理的细胞中,FTO过度表达促进了细胞活力,并抑制了高葡萄糖处理的细胞中的灭.
- FTO直接与NLRP3结合,调节其m6A修饰并抑制其表达,从而在体内减轻损伤.
结论:
- 在DKD中,FTO通过抑制NLRP3介导的热起着保护作用.
- FTO调节了NLRP3 m6A的修改,从而抑制了DKD的进展.
- 针对FTO可能代表管理DKD的治疗策略.
相关概念视频
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:26Nephrotic Syndrome II : Assessment and Medical Management
2
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
2
01:24Nephrotic Syndrome I : Introduction
2
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
2
01:28Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2